Biodesix (BDSX) Asset Writedowns and Impairment (2019 - 2026)
Biodesix (BDSX) reported Asset Writedowns and Impairment of $5000.0 for Q1 2026, down 93.15% on a YoY basis from $73000.0 in Q1 2025, and up 108.77% quarter-over-quarter from -$57000.0 in Q4 2025.
Biodesix (BDSX) Asset Writedowns and Impairment (2019 - 2026) Analysis & Trends
Biodesix has reported Asset Writedowns and Impairment for 8 years, with the latest figure at $5000.0 in Q1 2026.
- For the quarter ending Q1 2026, Asset Writedowns and Impairment fell 93.15% year-over-year to $5000.0; the trailing twelve-month figure through Mar 2026 stood at -$19000.0 (down 107.82% YoY), and the FY2025 full-year result was $49000.0, down 79.41% from the prior year.
- Asset Writedowns and Impairment for Q1 2026 stood at $5000.0, up from -$57000.0 in the prior quarter.
- The five-year high for Asset Writedowns and Impairment was $539000.0 in Q2 2022, with the low at -$419000.0 in Q3 2022.
- Historically, Asset Writedowns and Impairment has averaged $36562.5 across 5 years, with a median of $28000.0 in 2023.
- Annual changes were most pronounced in 2024 — Asset Writedowns and Impairment soared 770.0% — and 2025, when it slumped 155.34%.
- Biodesix's Asset Writedowns and Impairment stood at $12000.0 in 2022, then jumped by 733.33% to $100000.0 in 2023, then advanced by 3.0% to $103000.0 in 2024, then slumped by 155.34% to -$57000.0 in 2025, then jumped by 108.77% to $5000.0 in 2026.
- The last three Asset Writedowns and Impairment figures came in at $5000.0 (Q1 2026), -$57000.0 (Q4 2025), and $7000.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Waters | 30,529.42 Bn | 30,528.96 Bn | 1.11 Bn |
| 2 | Thermo Fisher Scientific | 183.75 Bn | 180.50 Bn | 7.74 Bn |
| 3 | Danaher | 133.13 Bn | 127.43 Bn | 3.59 Bn |
| 4 | Idexx Laboratories | 46.14 Bn | 45.94 Bn | 722.74 Mn |
| 5 | Agilent Technologies | 38.20 Bn | 36.39 Bn | 990.00 Mn |
| 6 | Natera | 31.50 Bn | 30.40 Bn | 696.04 Mn |
| 7 | Iqvia Holdings | 31.34 Bn | 29.36 Bn | 1.36 Bn |
| 8 | Illumina | 24.51 Bn | 23.36 Bn | 721.00 Mn |
| 9 | Mettler Toledo International | 23.53 Bn | 23.47 Bn | 555.82 Mn |
| 10 | Biodesix | 146.77 Mn | 121.20 Mn | 21.35 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 5,000.00 |
| Mar 31, 2026 | 5,000.00 |
| Dec 31, 2025 | -57,000.00 |
| Dec 31, 2025 | -57,000.00 |
| Sep 30, 2025 | 7,000.00 |
| Sep 30, 2025 | 7,000.00 |
| Jun 30, 2025 | 26,000.00 |
| Jun 30, 2025 | 26,000.00 |
| Mar 31, 2025 | 73,000.00 |
| Mar 31, 2025 | 73,000.00 |
| Dec 31, 2024 | 103,000.00 |
| Dec 31, 2024 | 103,000.00 |
| Jun 30, 2024 | 67,000.00 |
| Jun 30, 2024 | 67,000.00 |
| Mar 31, 2024 | 68,000.00 |
| Mar 31, 2024 | 68,000.00 |
| Dec 31, 2023 | 100,000.00 |
| Dec 31, 2023 | 100,000.00 |
| Sep 30, 2023 | 80,000.00 |
| Sep 30, 2023 | 80,000.00 |